Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways
- Conditions
- MonitoringAcute DiseaseClinical Deterioration
- Interventions
- Other: Usual CareDevice: Wearable Sensor
- Registration Number
- NCT05181111
- Lead Sponsor
- Rijnstate Hospital
- Brief Summary
Hospitals aim to hospitalize patients when necessary and discharge patients when possible. However, the triage process and discharge management of patients in e.g. the Acute Admission Ward, is not a trivial task. The upcoming technology of wearable monitoring devices, whereby patients can be continuously monitored with an unobtrusive vital signs device, might help getting more insight into patients' health condition and thus help facilitate efficient and effective triaging.
Therefore, the primary objective is to assess the effects of continuous monitoring of patients in the acute admission ward (AAW) on the percentage of patients who can be discharged home. Secondary objectives are to assess the length of stay in the acute admission ward and in the in-hospital wards, as well as the effect on admission to the intensive care unit, rapid response team calls and hospital readmission. The predictive value of algorithms applied to the monitoring data combined with other parameters to detect timely deterioration and predict discharge will be assessed. Facilitators and barriers for implementing such a system will be investigated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 800
In order for a patient to be eligible to participate in this study, the following criteria need to be met:
- admitted to the AAW
- Age ≥ 18 years
- Able to speak and read Dutch
- Willing and able to provide written informed consent
A patient who meets any of the following criteria will be excluded from participation:
- Not able or willing to wear a wearable sensor on the chest continuously for 14 days
- Planned major surgery in the upcoming 30 days
- At the time of AAW admission already known to be discharged home or admitted to the hospital
- Any skin condition, for example prior rash, discoloration, scars, infection, injury or open wounds at the area (Left lower rib) where the sensor needs to be placed
- Known sensitivity to medical adhesives
- Wearing an active implantable device (e.g. ICD, pacemaker)
- Intend to go to the sauna or go swimming in the upcoming 14 days
- Pregnant or breastfeeding
- Use of creams or lotions that are known to influence the skin at the area where sensor is placed (such as medical and non-medical creams or lotions)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual Care group Usual Care usual care monitoring Monitoring Group Wearable Sensor wearable sensor, besides usual care monitoring Monitoring Group Usual Care wearable sensor, besides usual care monitoring
- Primary Outcome Measures
Name Time Method Percentage of patients discharged home from acute admission ward up to 7 days Percentage of patients discharged home from acute admission ward
- Secondary Outcome Measures
Name Time Method Length of stay in the acute admission ward up to 7 days Length of stay in the acute admission ward
Percentage of Intensive Care Unit Admissions up to 31 days Percentage of Intensive Care Unit Admissions
Length of stay in the in-hospital wards up to 31 days Length of stay in the in-hospital wards
Percentage of Rapid Response Team calls up to 31 days Percentage of Rapid Response Team calls
Percentage of unplanned readmissions to the hospitals up to 31 days Percentage of unplanned readmissions to the hospitals
Trial Locations
- Locations (1)
Rijnstate Hospital
🇳🇱Arnhem, Netherlands